GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

picankibart   Click here for help

GtoPdb Ligand ID: 14398

Synonyms: IBI 112 | IBI-112 | IBI112 | Pecondle® (China)
Approved drug
picankibart is an approved drug
Compound class: Antibody
Comment: Picankibart (IBI112) is a humanized monoclonal antibody that targets human IL-23A p19 subunit, for anti-inflammatory potential [1]. The antibody neutralises IL-23-mediated receptor signalling and blocks downstream signal transducer and activator of transcription 3 (STAT3) phosphorylation and IL-17 production.
Classification Click here for help
Compound class Antibody
Approved drug? Yes. China NMPA (2025)
International Nonproprietary Names Click here for help
INN number INN
12419 picankibart
Synonyms Click here for help
IBI 112 | IBI-112 | IBI112 | Pecondle® (China)
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1420
Other databases
Search PubMed clinical trials picankibart
Search PubMed titles picankibart
Search PubMed titles/abstracts picankibart